Zepp Health Return on Equity (ROE) Growth & History (ZEPP)
Zepp Health's return on equity was −17.19% for fiscal 2025.
View full Zepp Health company overviewZepp Health annual return on equity history
| Fiscal year | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −17.19% | +7.95 pp |
| 2024 | 2024-12-31 | −25.14% | −16.74 pp |
| 2023 | 2023-12-31 | −8.40% | +1.82 pp |
| 2022 | 2022-12-31 | −10.23% | −15.16 pp |
| 2021 | 2021-12-31 | 4.93% | −4.08 pp |
| 2020 | 2020-12-31 | 9.02% | −17.52 pp |
| 2019 | 2019-12-31 | 26.54% | −6.64 pp |
| 2018 | 2018-12-31 | 33.18% | — |
Zepp Health quarterly return on equity
| Fiscal quarter | Period ended | Return on equity | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −5.98% | −2.59 pp |
| Q1 2026 | 2026-03-31 | −9.61% | −1.45 pp |
| Q4 2025 | 2025-12-31 | −4.98% | — |
| Q3 2025 | 2025-09-30 | −0.72% | — |
| Q2 2025 | 2025-06-30 | −3.38% | — |
| Q1 2025 | 2025-03-31 | −8.16% | — |
Zepp Health return on equity trends
Over the last five fiscal years, Zepp Health's return on equity decreased from 9.02% to −17.19%, a change of −26.21 percentage points. The latest reported quarter, Q2 2026, shows −5.98%.
What return on equity (ROE) means
Return on equity (ROE) measures how much net income a company generates relative to shareholders’ equity. It can help evaluate how efficiently equity capital is used, but unusually high or negative values may reflect leverage, losses, or a small equity base.
How return on equity is calculated
TickerStat calculates ROE as SEC-reported net income divided by average stockholders’ equity at the beginning and end of the fiscal period. Periods with missing or non-positive average equity are omitted. Quarterly ROE uses quarterly net income and is not annualized. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Zepp Health source filings ↗